(Q35145589)

6 August 2017

1 reference

title

Herbal agents and over-the-counter medications in pregnancy (English)

1 reference

6 August 2017

author name string

Elizabeth Ann Conover

series ordinal

1

1 reference

6 August 2017

publication date

1 June 2003

1 reference

Best Practice and Research: Clinical Endocrinology and Metabolism

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

237-251

1 reference

Effect of over-the-counter drugs on the unborn child: what is known and how should this influence prescribing?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Medication in early pregnancy: Prevalence of use and relationship to maternal characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Prenatal use of medications by women giving birth at a university hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Use of prescription and non-prescription drugs in pregnancy. The Baltimore-Washington Infant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

St John's wort: a hidden risk for transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Effect of ginger tea on the fetal development of Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Ginger treatment of hyperemesis gravidarum

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Effect of pinealectomy and melatonin treatment during pregnancy on the sexual development of the female and male rat offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Effect of prenatally administered hypericum (St John's wort) on growth and physical maturation of mouse offspring.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Effect of antenatal exposure to Saint John's wort (Hypericum) on neurobehavior of developing mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

First-trimester drug use and congenital disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Maternal medication use and risks of gastroschisis and small intestinal atresia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Maternal medications and environmental exposures as risk factors for gastroschisis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Prenatal exposure to salicylates and gastroschisis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Effects of aspirin and acetaminophen in pregnancy and in the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Attributable fraction for cardiac malformations

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Effect of a single dose of oral pseudoephedrine on uterine and fetal Doppler blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

The safety of dextromethorphan in pregnancy : results of a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Epidemiologic analysis of prenatal exposure to cough medicines containing dextromethorphan: no evidence of human teratogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Use of antihistamine drugs in early pregnancy and delivery outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Letter: Cleft palate and maternal diphenhydramine intake

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Prospective controlled study of hydroxyzine and cetirizine in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

The safety of asthma and allergy medications during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

The safety of proton pump inhibitors in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

The safety of omeprazole during pregnancy: A multicenter prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Prospective, controlled, multicentre study of loperamide in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Maternal corticosteroid use and risk of selected congenital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Population-based case-control study of teratogenic potential of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

Teratogenicity study on pyrethrum and rotenone (natural origin) and ronnel in pregnant rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900102-1

1 reference

7 January 2021

10.1016/S1521-690X(02)00102-1

Identifiers

DOI

1 reference

6 August 2017

1 reference